Intervet opens facility for vaccines in NL
Intervet, a producer of animal vaccines, has several
biological production sites throughout the world and will now open a new
facility in Boxmeer, the Netherlands.
Intervet makes use of three different technologies to produce antigens (a
molecule that stimulates an immune response and is used in vaccines):
Bacteriological production, production in eggs and tissue culture.
Boxmeer's current facility already produces bacteriological antigens via
production in fermenters. The additional facility will allow for tissue culture
for virological production. This method is preferable to production than the
eggs process - less labor extensive, possible to control and monitor the
production the parameters and less risk of production problems.
The new Tissue Culture Boxmeer (TCB) meets the quality requirements and
complies with all the rules of Good Manufacturing
. â€œThe technology and facilities are state of the art,â€ said
Milson Gondim, TCB manager.
To comment, login here
Or register to be able to comment.